Assessing the Effect of the MYODM Food Supplement on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1
The purpose of this study is to determine whether MYODM (formulated composition containing Theobroma cacao supplemented with caffeine (caffeine/theobromine ratio1/1.85, w/w) is effective in the treatment of excessive daytime sleepiness due to myotonic dystrophy type 1 (DM1) and improves the quality of life of these patients.
100 项与 Myogem Health Co. SL 相关的临床结果
0 项与 Myogem Health Co. SL 相关的专利(医药)
100 项与 Myogem Health Co. SL 相关的药物交易
100 项与 Myogem Health Co. SL 相关的转化医学